Nuvalent Executives Sell 12,220 Shares for $1.09M, Trimming Stakes by Up to 8.9%
Nuvalent insiders Deborah Ann Miller, Christopher Durant Turner and CFO Alexandra Balcom sold a combined 12,220 shares between January 5–6 at average prices of $97.16–$97.32, generating approximately $1.09 million in proceeds. These sales reduced Miller’s stake by 8.89%, Turner’s by 6.77% and Balcom’s by 4.75%.
1. Significant Insider Sale by Deborah Ann Miller
On January 5, Nuvalent’s Chief Business Officer, Deborah Ann Miller, sold 4,363 shares of company stock for a total of $424,607.16. Following the transaction she holds 44,723 shares, representing an 8.89% decline in her personal stake. This transaction was disclosed via an SEC Form 4 filing and marks the fourth sale by Miller in the past three months.
2. Cumulative Insider Dispositions This Quarter
In addition to the January 5 sale, Miller disposed of 2,589 shares on January 6, and earlier in Q4 sold 24,200 shares on November 17, 21,800 shares on October 30, 5,000 shares on October 20, 12,376 shares on October 16, and 15,624 shares on October 15. These seven transactions together account for 86, (–) total shares sold valued at over $8 million, indicating a notable decrease in insider holdings over the period.
3. Analyst Ratings and Institutional Activity
Nuvalent has received fifteen Buy recommendations and one Sell recommendation from leading brokerages. Consensus targets range around $138.33 per share, with occasional upward revisions by firms such as Robert W. Baird (to $158) and Stifel Nicolaus (to $135). Institutional ownership remains high at over 97%, with notable positions increased by GAMMA Investing LLC (up 47.6%) and Farther Finance Advisors LLC (up over 9,000%).